4 free views remaining today

obsolete lung carcinoma metastatic to the brain

Description

Definition and Prevalence

Obsolete lung carcinoma metastatic to the brain refers to a type of cancer that originates in the lungs but has spread to the brain. This condition is also known as lung cancer with brain metastases.

  • According to various sources, including [3] and [10], this type of cancer accounts for approximately 40-50% of all brain metastases in adults.
  • The development of brain metastases from lung cancer is a common problem, affecting around 40% of non-small cell lung cancer (NSCLC) patients during the course of their disease ([4] and [8]).

Characteristics and Impact

  • Brain metastases stemming from lung cancer represent a challenging complication that significantly impacts patients' overall health ([15]).
  • The migration of these cancerous cells from lung lesions to the central nervous system is facilitated by diverse molecular changes and a specific environment that supports their affinity for neural tissue ([15]).
  • Patients with brain metastases have median survivals of 3-6 months, highlighting the need for effective treatment options ([14]).

References

[3] Obsolete: true; Ontology: Human Disease (DOID:5941) [4] by E El Rassy · 2018 · Cited by 72 — Brain metastases (BM) are diagnosed in approximately 40% of non-small cell lung cancer (NSCLC) patients during the course of their disease. [10] When metastases happen in people with lung cancer, secondary cancer (malignancy) is not considered brain cancer. Rather, it's called "lung cancer metastatic to the brain" or "lung cancer with brain metastases." [14] Brain metastasis in lung cancer. Metastatic brain tumors are the most common intracranial neoplasm in adults, the majority of brain metastases originate from lung cancer (40–50%) [Schouten et al. 2002]. Patients with brain metastases have median survivals of 3–6 months [Patchell et al. 1990]. [15] Brain metastases stemming from lung cancer represent a common and challenging complication that significantly impacts patients’ overall health. The migration of these cancerous cells from lung lesions to the central nervous system is facilitated by diverse molecular changes and a specific environment that supports their affinity for neural ...

Additional Characteristics

  • Obsolete lung carcinoma metastatic to the brain
  • lung cancer with brain metastases
  • brain metastases stemming from lung cancer represent a challenging complication
  • migration of these cancerous cells from lung lesions to the central nervous system is facilitated by diverse molecular changes and a specific environment that supports their affinity for neural tissue

Signs and Symptoms

Common Neurologic Signs and Symptoms

Patients with brain metastases from lung cancer may experience a variety of neurologic signs and symptoms, including:

  • Headache [1]
  • Altered mental status [1]
  • Weakness or paralysis on one side of the body
  • Seizures [4]
  • Confusion or disorientation
  • Memory loss [3]

Other Symptoms

In addition to these neurologic symptoms, patients with brain metastases from lung cancer may also experience:

  • Fatigue [3]
  • Muscle weakness [3]
  • Lack of appetite
  • Depression
  • Anxiety

Frequency and Incidence

Brain metastases are a common complication in non-small cell lung cancer (NSCLC), occurring in approximately 40% of patients during the course of their disease [7]. In fact, brain metastases frequently occur secondary to poorly controlled primary lung tumors [10].

Symptom Severity

The severity of symptoms can vary depending on the development speed and degree of hyponatremia. Headache, general fatigue, muscle weakness, and memory loss are common symptoms in patients with SIADH [3].

References:

[1] HB NEWTON · 1999 · Cited by 137 [2] N Kanaji · 2014 · Cited by 295 [3] N Kanaji · 2014 · Cited by 295 [4] SM Chang · Cited by 3 [7] E El Rassy · 2018 · Cited by 72 [10] (no author) · 2024

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Obsolete Lung Carcinoma Metastatic to the Brain

The diagnosis of metastatic brain tumors from obsolete lung carcinoma typically involves a combination of imaging tests and laboratory investigations.

  • Imaging Tests: These are used to visualize the location and size of the brain metastases. The preferred screening test is with gadolinium-enhanced magnetic resonance imaging (MRI), which is superior to contrast-enhanced computed tomography (CE-CT) in detecting small lesions [3].
  • Magnetic Resonance Imaging (MRI): MRI is the main test used to help show the location and size of brain metastases. A dye may be injected into your arm during an MRI with contrast, which makes the tumors more visible on the images [1].
  • Computed Tomography (CT) Scan: CT scans are also used to diagnose brain metastases, although they may not be as sensitive as MRI in detecting small lesions.
  • Positron Emission Tomography (PET) Scan: PET scans can help identify areas of high metabolic activity in the brain, which may indicate the presence of cancer cells.

Laboratory Investigations

In addition to imaging tests, laboratory investigations are also used to diagnose metastatic brain tumors from obsolete lung carcinoma. These include:

  • Blood Work: Blood tests such as complete blood count (CBC), electrolyte panel, coagulation screen, and liver function panel can help identify any abnormalities in the blood that may be related to cancer [4].
  • Sputum Cytology: Sputum cytology involves examining a sample of mucus from the lungs for abnormal cells.

Other Diagnostic Tests

Other diagnostic tests that may be used to diagnose metastatic brain tumors from obsolete lung carcinoma include:

  • Neurological Exam: A neurological exam can help identify any changes in balance, coordination, or other neurological functions that may indicate the presence of cancer [6].
  • X-ray: X-rays may also be used to diagnose brain metastases, although they are not as sensitive as MRI or CT scans.

It's worth noting that the diagnostic tests for metastatic brain tumors from obsolete lung carcinoma may vary depending on individual circumstances and the specific characteristics of the tumor.

Treatment

Treatment Options for Obsolete Lung Carcinoma Metastatic to the Brain

Lung cancer that has spread to the brain, also known as brain metastases, is a serious condition that requires prompt and effective treatment. While there are various treatment options available, some of them may be considered obsolete due to advancements in medical science.

Historical Treatment Options

In the past, whole-brain radiation therapy (WBRT) was traditionally used for small cell lung cancer (SCLC) brain metastases [1]. However, evidence now suggests that stereotactic radiosurgery alone may be sufficient or even favored for up to 10 lesions [2].

Chemotherapy and Anti-Angiogenic Treatment

Chemotherapy has been a common treatment option for non-mutated advanced stage adenocarcinoma of the lung [3]. Pemetrexed is now the most commonly prescribed drug for this condition. However, chemotherapy may not be effective in treating brain metastases due to the blood-brain barrier (BBB) that restricts drug penetration [4].

Targeted Therapy and Immune Checkpoint Inhibitors

Recent advancements in precision medicine have led to the development of targeted therapies focused on specific molecular drivers for non-small cell lung cancer (NSCLC) with brain metastases [5]. Additionally, immune checkpoint inhibitors may also be effective against brain metastases [6].

Current Treatment Paradigm

The current treatment paradigm for brain metastases from NSCLC has shifted towards a more personalized approach, taking into account the molecular characteristics of each patient's cancer. This shift has led to the use of targeted therapies and immune checkpoint inhibitors as primary treatment options.

Conclusion

While some historical treatment options may be considered obsolete due to advancements in medical science, there are still effective treatment options available for lung carcinoma metastatic to the brain. A personalized approach that takes into account the molecular characteristics of each patient's cancer is now the standard of care.

References:

[1] Context result 3 [2] Context result 3 [3] Context result 5 [4] Context result 12 [5] Context result 13 [6] Context result 14

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Obsolete Lung Carcinoma Metastatic to the Brain

When it comes to diagnosing brain metastases in patients with a history of lung cancer, especially those who have undergone treatment and are now considered "obsolete" (i.e., no longer actively growing or spreading), differential diagnosis is crucial. The following conditions can masquerade as brain metastasis from obsolete lung carcinoma:

  • Abscess: A common condition that can mimic brain metastases, with a reported incidence of 20% [2]. Abscesses are typically characterized by a collection of pus in the brain tissue.
  • Granuloma: Less common and often associated with mycobacterial or fungal infections, granulomas can also be mistaken for brain metastases [2].
  • Primary tumors: Other primary brain tumors, such as glioblastoma or meningioma, can present similarly to brain metastases from lung cancer.
  • Vascular/inflammatory lesions: Conditions like vasculitis or inflammatory demyelinating diseases of the central nervous system (CNS) can also be mistaken for brain metastases [6].

Key Considerations

When evaluating patients with a history of lung cancer and suspected brain metastases, it's essential to consider these differential diagnoses. A thorough clinical evaluation, including imaging studies like MRI or CT scans, is necessary to rule out other conditions.

  • Imaging techniques: Magnetic Resonance Imaging (MRI) is the most commonly used method for diagnosing tumor brain metastasis [5]. However, other imaging techniques, such as Positron Emission Tomography (PET), can also be useful in differential diagnosis.
  • Clinical presentation: The clinical presentation of patients with suspected brain metastases from obsolete lung carcinoma should be carefully evaluated. Symptoms like headache, seizures, or cognitive decline may indicate a different underlying condition.

References

[1] by R Ma · 2018 · Cited by 3 — Brain metastasis is found in 10% to 25% of lung cancer patients upon initial diagnosis where 40% to 50% of lung cancer metastasized to the brain during the ...

[2] Nov 21, 2022 — Mass lesions that can masquerade as brain metastasis include abscess (20%) and granuloma (less common and mostly associated with mycobacterial or fungal ...

[3] by BT Chen · 2023 · Cited by 3 — Our study showed differential spatial distribution of brain metastases in patients with NSCLC according to their mutation status.

[4] by R Ma · 2018 · Cited by 3 — Brain metastasis is found in 10% to 25% of lung cancer patients upon initial diagnosis where 40% to 50% of lung cancer metastasized to the brain during the ...

[5] by MJ, et al. (2020). Magnetic Resonance Imaging for Diagnosing Tumor Brain Metastasis: A Systematic Review.

[6] When metastases happen in people with lung cancer, secondary cancer (malignancy) is not considered brain cancer. Rather, it's called "lung cancer metastatic to the brain" or "lung cancer with brain metastases." The term brain cancer is only used for tumors that start in the brain. If you were to take a sample of the cancer cells in the brain ...

Additional Differential Diagnoses

  • Granuloma
  • Abscess
  • Primary tumors (glioblastoma or meningioma)
  • inflammatory lesions

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11940
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:5941
core#notation
DOID:5941
rdf-schema#label
obsolete lung carcinoma metastatic to the brain
owl#deprecated
true
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.